<h2>EPCLUSA Drug Profile, 2023</h2>
<p>This report focuses on EPCLUSA and covers the following critical aspects of this drug:</p>
<ul><li>United States patents</li>
<li>District Court patent litigation</li>
<li>Patent Trial and Appeal Board (PTAB) patent cases</li>
<li>European supplementary protection certificates (SPCs)</li>
<li>Clinical trials</li>
<li>Drug prices</li>
<li>Finished product suppliers</li>
</ul>